Table 3.
Analysis | Incident CAD | Incident stoke |
---|---|---|
HR with 95% CI*, p-value | HR with 95% CI*, p-value | |
Unadjusted analysis | 1.26 (1.15-1.38), <0.001 | 1.55 (1.38-1.73), <0.001 |
Adjusted analysis #1 | 1.38 (1.25-1.52), <0.001 | 1.56 (1.38-1.76), <0.001 |
Adjusted analysis #2 | 1.38 (1.25-1.52), <0.001 | 1.54 (1.36-1.74), <0.001 |
Adjusted analysis #3 | 1.33 (1.20-1.47), <0.001 | 1.49 (1.32-1.69), <0.001 |
Adjusted analysis #4 | 1.26 (1.14-1.40), <0.001 | 1.46 (1.29-1.65), <0.001 |
Adjusted analysis #5 | 1.35 (1.17-1.57), <0.001 | 1.55 (1.30-1.85), <0.001 |
Footnotes:
V15.81“-” group served as a reference group for all analyzes; HR, hazard ratio; CI, confidence interval; CAD, coronary artery disease; Adjusted analysis 1, adjusted analysis for age, gender, race, mean income, marital status, area-level housing stress, low education, low employment and persistent poverty; Adjusted analysis 2, adjusted analysis 1 plus estimated glomerular filtration rate (eGFR); Adjusted analysis 3, adjusted analysis 2 plus baseline comorbidities; Adjusted analysis 4, adjusted analysis 3 plus baseline systolic and diastolic blood pressure and body mass index. Adjusted analysis 5, adjusted analysis 4 plus adherence to antihypertensive drugs.